News
Video
Author(s):
Key factors influencing frontline treatment choices in endometrial cancer, including biomarker status, comorbidities, guidelines, and patient preferences, with a focus on the evolving landscape of therapies.
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
The OncFive: Top Oncology Articles for the Week of 10/27
Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors
The Top News From ESMO 2024: A Variety of Data Inform Solid Tumor Landscapes
The OncFive: Top Oncology Articles for the Week of 10/20
DK210 (EGFR) Induces Immune Response Without Increased CRS or Regulatory T Cells in Solid Tumors
Siglec-15 Represents Potential Therapeutic Target in NSCLC, Other Solid Tumors
Radiomic Biomarkers Predict Response in Lung and Liver Uveal Melanoma Metastases